FDA Recall of Genius Review Station Display
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has initiated a recall of 1200 units of the Genius Review Station Display due to devices being operated outside validated settings from user modifications.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 13, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
The recall was initiated because certain devices were operated outside the validated and FDA-cleared display configuration due to user modifications, such as disabling the Barco Application Appearance Manager (AAM), altering calibration and compliance parameters, and adjusting other display-related settings. This field correction aims to restore the affected systems to the validated configuration and reinforce proper use as per the Operator's Manual.
Which Products Are Affected
The affected product is the Genius Review Station Display (Barco Monitor), which is a component of the Genius Digital Diagnostics System. The model or catalog number is CMP-01669, with UDI-DI: 15420045514201, and it applies to all serial numbers. Approximately 1200 units are affected, distributed US Nationwide and in regions including Asia Pacific, Europe, and the Middle East. The recall number is Z-1949-2026.
What You Should Do
Consumers should follow the initial firm notification, which was sent via letter, to restore the affected systems to the validated configuration. Contact the recalling firm, Hologic, Inc., at 250 Campus Dr, Marlborough, MA 01752-3020, for further instructions on this voluntary recall.
Why This Matters
This recall ensures that medical devices are used in their validated configurations to maintain accuracy in diagnostics, potentially preventing errors in healthcare settings. It highlights the importance of adhering to manufacturer guidelines for safety and regulatory compliance.
Source
Attribution: FDA Recall Notice Z-1949-2026. For more information, refer to the FDA's official recall database.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,645 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 13, 2026.
Frequently Asked Questions
Common questions about this FDA recall.